Genetic variation at a splicing branch point in intron 9 of the low density lipoprotein (LDL)-receptor gene: a rare mutation that disrupts mRNA splicing in a patient with familial hypercholesterolaemia and a common polymorphism [PDF]
J. L. Webb
openalex +1 more source
Age Estimation From Blood Test Results Using a Random Forest Model
From the perspective of preventive medicine, it is essential to clarify the relationship between medical examination data and aging and health problems. We successfully and accurately estimated age from clinical examination data using a random forest model. Postmenopausal women tended to have higher age estimates than premenopausal women.
Satomi Kodera+5 more
wiley +1 more source
Inhibition of a novel Dickkopf-1-LDL receptor-related proteins 5 and 6 axis prevents diabetic cardiomyopathy in mice. [PDF]
Ma E+17 more
europepmc +1 more source
MT1-MMP Expression Levels and Catalytic Functions Dictate LDL Receptor-Related Protein-1 Ligand Internalization Capacity in U87 Glioblastoma Cells. [PDF]
Pratt J, Haidara K, Annabi B.
europepmc +1 more source
Comparison of Univariate and Multivariate Reference Interval Methods
ABSTRACT Background In clinical practice, reference intervals play a pivotal role in interpreting laboratory test results. Yet, when several tests are taken into consideration simultaneously, the traditional univariate intervals might not suffice due to the elevated risk of Type 1 errors.
Esra Kutsal Mergen, Sevilay Karahan
wiley +1 more source
Abstract Compared to traditional small molecule drugs, monoclonal antibodies (mAbs) often display more complex pharmacokinetic (PK) and pharmacodynamic (PD) properties that may be impacted by disease‐specific factors. For mAbs in non‐oncology indications, where the same drug might be used for conditions involving different organ systems and/or having ...
Sherouk M. Tawfik, Fei Tang
wiley +1 more source
Schisandrin A in Schisandra chinensis Upregulates the LDL Receptor by Inhibiting PCSK9 Protein Stabilization in Steatotic Model. [PDF]
Kim HJ+6 more
europepmc +1 more source
Abstract Fenofibrate is contraindicated in patients with advanced hepatic fibrosis due to limited clinical data. We evaluated the pharmacokinetics and safety of fenofibrate in participants with mild hepatic impairment (phase 1 study) or advanced fibrosis due to metabolic‐associated fatty liver disease (MAFLD; phase 2a study).
Islam R. Younis+5 more
wiley +1 more source
Abstract Background To assess the effects of a two‐night hospitalization program conducted at our hospital as part of a domestic health guidance system. This program is designed for lifestyle modification within a health checkup framework for metabolic syndrome. Methods This is a single‐center, retrospective observational study. We reviewed the medical
Maki Okazaki+5 more
wiley +1 more source